Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT02689336 |
Title | Erlotinib in Combination With Temozolomide in Treating Relapsed/Recurrent/Refractory Pediatric Solid Tumors |
Recruitment | Withdrawn |
Gender | both |
Phase | Phase II |
Variant Requirements | Yes |
Sponsors | Washington University School of Medicine |
Indications | |
Therapies | |
Age Groups: | adult | child |
Covered Countries |
Facility | Status | City | State | Zip | Country | Details |
---|